Neuron-oligodendrocyte potassium shuttling at nodes of Ranvier protects against inflammatory demyelination.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
03 04 2023
Historique:
received: 09 08 2022
accepted: 27 01 2023
medline: 4 4 2023
pubmed: 1 2 2023
entrez: 31 1 2023
Statut: epublish

Résumé

Multiple sclerosis (MS) is a progressive inflammatory demyelinating disease of the CNS. Increasing evidence suggests that vulnerable neurons in MS exhibit fatal metabolic exhaustion over time, a phenomenon hypothesized to be caused by chronic hyperexcitability. Axonal Kv7 (outward-rectifying) and oligodendroglial Kir4.1 (inward-rectifying) potassium channels have important roles in regulating neuronal excitability at and around the nodes of Ranvier. Here, we studied the spatial and functional relationship between neuronal Kv7 and oligodendroglial Kir4.1 channels and assessed the transcriptional and functional signatures of cortical and retinal projection neurons under physiological and inflammatory demyelinating conditions. We found that both channels became dysregulated in MS and experimental autoimmune encephalomyelitis (EAE), with Kir4.1 channels being chronically downregulated and Kv7 channel subunits being transiently upregulated during inflammatory demyelination. Further, we observed that pharmacological Kv7 channel opening with retigabine reduced neuronal hyperexcitability in human and EAE neurons, improved clinical EAE signs, and rescued neuronal pathology in oligodendrocyte-Kir4.1-deficient (OL-Kir4.1-deficient) mice. In summary, our findings indicate that neuron-OL compensatory interactions promoted resilience through Kv7 and Kir4.1 channels and identify pharmacological activation of nodal Kv7 channels as a neuroprotective strategy against inflammatory demyelination.

Identifiants

pubmed: 36719741
pii: 164223
doi: 10.1172/JCI164223
pmc: PMC10065072
doi:
pii:

Substances chimiques

Potassium RWP5GA015D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Références

Elife. 2016 Sep 27;5:
pubmed: 27671734
Nat Rev Neurosci. 2000 Oct;1(1):21-30
pubmed: 11252765
J Physiol. 2006 Aug 15;575(Pt 1):175-89
pubmed: 16777937
J Neuroinflammation. 2019 Nov 4;16(1):203
pubmed: 31684959
Br J Pharmacol. 2009 Apr;156(8):1185-95
pubmed: 19298256
Brain Pathol. 2011 Jul;21(4):428-40
pubmed: 21114565
Vision Res. 2006 Mar;46(6-7):902-13
pubmed: 16242750
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
Clin Neurophysiol. 2004 Apr;115(4):956-65
pubmed: 15003779
Neurology. 2007 Apr 10;68(15):1197-204
pubmed: 17420403
Brain. 2006 Dec;129(Pt 12):3186-95
pubmed: 16766541
J Exp Med. 2021 May 3;218(5):
pubmed: 33661276
Epilepsia. 2012 Mar;53(3):425-36
pubmed: 22221318
Cell Rep. 2021 Jul 20;36(3):109404
pubmed: 34289346
Nat Commun. 2020 Oct 30;11(1):5497
pubmed: 33127910
Ann Neurol. 2001 Sep;50(3):389-400
pubmed: 11558796
Front Cell Neurosci. 2017 Feb 27;11:45
pubmed: 28289377
Cell Mol Life Sci. 2016 Feb;73(4):723-35
pubmed: 26514731
J Neurosci. 2015 May 6;35(18):7272-86
pubmed: 25948275
Mol Pain. 2014 Feb 21;10:15
pubmed: 24555569
Nat Commun. 2021 Jan 4;12(1):23
pubmed: 33397944
JAMA Neurol. 2021 Feb 1;78(2):186-196
pubmed: 33226425
Nat Commun. 2020 Feb 10;11(1):812
pubmed: 32041951
J Neurosci. 2015 Jun 10;35(23):8829-42
pubmed: 26063916
Ann Neurol. 1979 Jan;5(1):22-31
pubmed: 426466
Nat Genet. 2003 Mar;33(3):366-74
pubmed: 12590258
Nat Commun. 2021 Sep 1;12(1):5219
pubmed: 34471138
Neuron. 2013 Jun 5;78(5):785-98
pubmed: 23764284
Nat Rev Neurosci. 2005 Nov;6(11):850-62
pubmed: 16261179
J Neurosci. 2004 Feb 4;24(5):1236-44
pubmed: 14762142
Brain Pathol. 2007 Apr;17(2):230-42
pubmed: 17388954
Nat Neurosci. 2018 Oct;21(10):1392-1403
pubmed: 30258239
Brain. 2013 Apr;136(Pt 4):1067-82
pubmed: 23518709
Ann Neurol. 2007 Jul;62(1):21-33
pubmed: 17654737
Epilepsia. 2012 Mar;53(3):412-24
pubmed: 22220513
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8870-5
pubmed: 16735477
Cancer Cell. 2008 Aug 12;14(2):123-34
pubmed: 18691547
Neurobiol Learn Mem. 2016 May;131:137-46
pubmed: 27038742
Exp Neurol. 2013 Oct;248:62-71
pubmed: 23748135
J Neurosci. 2007 Oct 17;27(42):11354-65
pubmed: 17942730
Brain. 2008 Jul;131(Pt 7):1722-35
pubmed: 18515320
Epilepsy Res. 1992 Sep;12(3):207-15
pubmed: 1396546
Phys Med Rehabil Clin N Am. 2013 Nov;24(4):717-20
pubmed: 24314688
PLoS One. 2016 Feb 24;11(2):e0150095
pubmed: 26910900
Neuron. 2018 Apr 18;98(2):306-319.e7
pubmed: 29606582
Sci Rep. 2016 Oct 13;6:35080
pubmed: 27734968
Nat Commun. 2021 Aug 10;12(1):4801
pubmed: 34376649
Nat Rev Neurol. 2020 Aug;16(8):426-439
pubmed: 32651566
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
Nature. 2018 Feb 14;554(7692):323-327
pubmed: 29446379
J Neurosci. 2014 Mar 5;34(10):3719-32
pubmed: 24599470
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8168-73
pubmed: 15148385
Elife. 2018 Mar 29;7:
pubmed: 29596047
Neurosci Lett. 2011 Nov 21;505(3):223-7
pubmed: 21945947
Neurology. 2011 May 3;76(18):1555-63
pubmed: 21451152
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19974-9
pubmed: 19060215
J Biol Chem. 2016 Mar 11;291(11):5566-5575
pubmed: 26733196
Exp Neurol. 2018 Nov;309:54-66
pubmed: 30048715
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Neurology. 2010 Nov 16;75(20):1817-24
pubmed: 20944074
Nat Rev Neurosci. 2006 Dec;7(12):932-41
pubmed: 17115075
Brain Behav Immun. 2017 Jan;59:103-117
pubmed: 27569659
Nature. 2019 Sep;573(7772):75-82
pubmed: 31316211
Science. 2019 May 17;364(6441):685-689
pubmed: 31097668
J Physiol. 2008 Apr 1;586(7):1823-32
pubmed: 18174210
Nature. 1998 Dec 17;396(6712):687-90
pubmed: 9872318
Nature. 2018 Nov;563(7729):72-78
pubmed: 30382198
Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):E191-E199
pubmed: 28003466
Brain. 2020 Apr 1;143(4):1127-1142
pubmed: 32293668
J Neurol Sci. 2005 Jun 15;233(1-2):3-13
pubmed: 15899499
Brain Res. 1991 Aug 16;556(2):311-6
pubmed: 1657307
Nat Rev Drug Discov. 2009 Dec;8(12):982-1001
pubmed: 19949402
Elife. 2018 Sep 11;7:
pubmed: 30204081
Nat Rev Neurol. 2014 Apr;10(4):225-38
pubmed: 24638138

Auteurs

Hannah Kapell (H)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Luca Fazio (L)

Department of Neurology with Institute of Translational Neurology, University Hospital Münster (UKM), Münster, Germany.
Department of Neurology, University of Düsseldorf, Dusseldorf, Germany.

Julia Dyckow (J)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Sophia Schwarz (S)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Andrés Cruz-Herranz (A)

Weill Institute for Neurosciences, Department of Neurology, UCSF, San Francisco, California, USA.

Christina Mayer (C)

Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Joaquin Campos (J)

Chica and Heinz Schaller Research Group, Institute of Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.

Elisa D'Este (E)

Optical Microscopy Facility, Max Planck Institute for Medical Research, Heidelberg, Germany.

Wiebke Möbius (W)

Electron Microscopy Core Unit, Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
Cluster of Excellence, "Multiscale Bioimaging: from Molecular Machines to Network of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany.

Christian Cordano (C)

Weill Institute for Neurosciences, Department of Neurology, UCSF, San Francisco, California, USA.

Anne-Katrin Pröbstel (AK)

Weill Institute for Neurosciences, Department of Neurology, UCSF, San Francisco, California, USA.
Neurologic Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience Basel, Departments of Medicine, Biomedicine, and Clinical Research, University Hospital of Basel, University of Basel, Basel, Switzerland.

Marjan Gharagozloo (M)

Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Amel Zulji (A)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Venu Narayanan Naik (V)

Department of Neurology with Institute of Translational Neurology, University Hospital Münster (UKM), Münster, Germany.

Anna Delank (A)

Department of Neurology with Institute of Translational Neurology, University Hospital Münster (UKM), Münster, Germany.

Manuela Cerina (M)

Department of Neurology with Institute of Translational Neurology, University Hospital Münster (UKM), Münster, Germany.

Thomas Müntefering (T)

Department of Neurology, University of Düsseldorf, Dusseldorf, Germany.

Celia Lerma-Martin (C)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Jana K Sonner (JK)

Chica and Heinz Schaller Research Group, Institute of Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.

Jung Hyung Sin (JH)

Weill Institute for Neurosciences, Department of Neurology, UCSF, San Francisco, California, USA.

Paul Disse (P)

Institute for Genetics of Heart Diseases (IfGH), Cellular Electrophysiology and Molecular Biology, UKM, Münster, Germany.
University of Münster, Chembion, Münster, Germany.

Nicole Rychlik (N)

University of Münster, Chembion, Münster, Germany.
Institute of Physiology I, University of Münster, Münster, Germany.

Khalida Sabeur (K)

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research and.
Department of Pediatrics, UCSF, San Francisco, California, USA.

Manideep Chavali (M)

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research and.
Department of Pediatrics, UCSF, San Francisco, California, USA.

Rajneesh Srivastava (R)

Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany.

Matthias Heidenreich (M)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.

Kathryn C Fitzgerald (KC)

Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Guiscard Seebohm (G)

Institute for Genetics of Heart Diseases (IfGH), Cellular Electrophysiology and Molecular Biology, UKM, Münster, Germany.

Christine Stadelmann (C)

Electron Microscopy Core Unit, Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.
Institute of Neuropathology, University Medical Center, Göttingen, Germany.

Bernhard Hemmer (B)

Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany.
Munich Cluster for Systems Neurology, Munich, Germany.

Michael Platten (M)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), INF 280, Heidelberg, Germany.
Interdisciplinary Center for Neurosciences (IZN) and.
Mannheim Center for Translational Neuroscience and Institute for Innate Immunoscience, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Thomas J Jentsch (TJ)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany.
Neurocure Cluster of Excellence, Charité University Medicine Berlin, Berlin, Germany.

Maren Engelhardt (M)

Mannheim Center for Translational Neuroscience and Institute for Innate Immunoscience, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Institute of Neuroanatomy, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Institute of Anatomy and Cell Biology, Johannes Kepler University Linz, Linz, Austria.

Thomas Budde (T)

Institute of Physiology I, University of Münster, Münster, Germany.

Klaus-Armin Nave (KA)

Electron Microscopy Core Unit, Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany.

Peter A Calabresi (PA)

Departments of Neurology and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Manuel A Friese (MA)

Institute of Neuroimmunology and Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Ari J Green (AJ)

Weill Institute for Neurosciences, Department of Neurology, UCSF, San Francisco, California, USA.
Department of Ophthalmology, UCSF, San Francisco, California, USA.

Claudio Acuna (C)

Chica and Heinz Schaller Research Group, Institute of Anatomy and Cell Biology, Heidelberg University, Heidelberg, Germany.

David H Rowitch (DH)

Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research and.
Department of Pediatrics, UCSF, San Francisco, California, USA.
Wellcome Trust-Medical Research Council Stem Cell Institute and.
Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
Department of Neurosurgery, UCSF, San Francisco, California, USA.

Sven G Meuth (SG)

Department of Neurology with Institute of Translational Neurology, University Hospital Münster (UKM), Münster, Germany.
Department of Neurology, University of Düsseldorf, Dusseldorf, Germany.

Lucas Schirmer (L)

Department of Neurology, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.
Interdisciplinary Center for Neurosciences (IZN) and.
Mannheim Center for Translational Neuroscience and Institute for Innate Immunoscience, Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH